Best Nucleic Podcasts (2025)

1
Episode 21: Historic Moment: Candace Owens Blazes New Media with Story of the USS Liberty: Plus, Bishops Craft a Potentially--Even Likely--Murderous Document: E. Michael Jones Chats with David Schmitt 37:11

Play Pause

6M ago37:11

37:11

On December 11, 2024, Candace Owens committed an act of not only journalism, but of history, with her conversation with former Navy man, Phil Tourney. Please see here: https://youtu.be/PD5gtM1A990. Miss Owens (now, Mrs. Farmer). During this discussion, the two discussed the event of the June 8, 2024 attack by aircraft and torpedo boats of the Israe…

1
Lighting the touch paper for next generation nucleic acid therapies 32:06

2y ago32:06

32:06

In this episode Mike Ward, Clarivate’s Head of Thought Leadership for Life sciences and healthcare, spoke to Johnny Ohlson, Founder of Touchlight, a company who has developed a novel synthetic DNA vector. In recent years, we've seen that by harnessing the power of DNA, it has been possible to achieve success in treating previously incurable heredit…

1
Realizing the patient-friendly future of clinical trials 23:02

3y ago23:02

23:02

In this episode of Conversations in Healthcare, Ergomed founder Dr. Miroslav Reljanović talks to Mike Ward about how the COVID-19 pandemic has nudged clinical trials towards greater efficiency and inclusivity – and what’s needed to make good on this promising trend. Hosted on Acast. See acast.com/privacy for more information.…

1
How Patient Connect addresses unmet needs at the point of care 22:32

3y ago22:32

22:32

In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Grace Lomax, Clinical Director at Patient Connect, a part of Clarivate. Grace’s experience as a physician highlighted numerous unmet needs beyond just clinical issues – especially around healthcare literacy, education at the point of care, adherence and more. She discusses ho…

1
Social determinants: barriers to healthcare impacting racial and ethnic minorities 45:59

3+ y ago45:59

45:59

In this episode of Conversations in Healthcare, Matthew Arnold, Principal Analyst at Clarivate speaks with Dr. Kenton Johnston, Associate Professor of Health Management and Policy at Saint Louis University about disparities in the US health system. Matthew and Ken discuss both the historical context as well as the evolution of the system since the …

1
How Novo Ventures prioritized their investment strategy during the pandemic 25:50

3+ y ago25:50

25:50

In this episode of Conversations in Healthcare, Mike Ward speaks with Naveed Saddiqi, Senior Partner at Novo Ventures, one of the largest venture capital groups in the life sciences sector. Naveed shares about the firm’s mandate to generate funds for the Novo Nordisk Foundation, how the pandemic impacted their investment strategy and what excites h…

1
How Healx uses AI to transform rare disease drug discovery 27:52

3+ y ago27:52

27:52

In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Tim Guilliams, the co-founder and CEO of Healx. Healx is an artificial intelligence-powered technology company that's dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosin…

1
How the pandemic shifted Roche’s priorities and R&D investments 31:20

3+ y ago31:20

31:20

In this episode of Conversations in Healthcare, Mike Ward speaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Richard shares how the pandemic has shifted Roche’s priorities and why the organization has heavily increas…

1
Optimizing patient-first clinical trials with advanced site intelligence 40:56

3+ y ago40:56

40:56

In this episode of Conversations in Healthcare, Mike Ward speaks with Oriol Serra, former Head of Site Intelligence and Selection at Pfizer and Simon Andrews, Vice President of RWD Engagements and Innovations at Clarivate about optimizing patient-first clinical trial design and ensuring trial groups align to real-life populations and needs. The gro…

1
Showing the value of regulatory intelligence in pharma 31:32

3+ y ago31:32

31:32

In this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. …

1
Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative 36:46

4y ago36:46

36:46

Increased reliance on telehealth services has been one of the most significant care delivery shifts prompted by the COVID-19 pandemic. However, the pandemic has also thrown more light on the challenges of health inequity in the United States, especially among African American and Hispanic communities. We discuss these issues and potential solutions…

1
Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research 27:59

4y ago27:59

27:59

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Toby Richardson, who is Head of Business Development and Licensing; Deputy Director of Business and Innovation at The Institute of Cancer Research. Mike and Toby discuss how research collaborations betwee…

1
Episode 20: Reproduction for Europeans and Christians--from Theory to Action: A Roundtable Discussion with E. Michael Jones, Brian McCall, Tim Kelly and David Schmitt 1:34:10

4y ago1:34:10

1:34:10

TIMELINE INDEX 1:42. “Condom Economics” 2:58. A clueless Catholic hierarchy 8:58. Tyranny, false order. 13:32. Reproduction, more than numbers: teleology needed. 15:12. Kingdom-building attitude. 16:53. Family wage. 24:04. Generosity. 26:17. “One more child that can be ‘reasonably’ expected,” 27:26. “Culture of Death.” 36:04. No despair: things rec…

1
Best practices for university – healthcare partnerships: Learnings from Oxford 35:15

4y ago35:15

35:15

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Phil Clare, the Deputy Director, Research Services (Knowledge Exchange and Engagement) at the University of Oxford. Mike and Dr. Clare discuss the key role that university research plays in shaping new me…

1
Episode 19: Dear Australia: The Confluence of Faith and Science in Practical Action 24:18

4y ago24:18

24:18

This Episode was recorded July 10, 2021 and posted July 11, 2021. The disproportionate and draconian action by policy makers must be addressed. Poor journalism and poor public policy: A mere 27 new "cases" Wednesday (severity unknown---or even whether symptomatic) out of a population of 5.4 million in Sydney. I am both a scientist and a man of fait…

1
Episode 18: Self-Protection and Citizenship: Getting the Most from a Podcast 37:57

4y ago37:57

37:57

Self-Protective Intellectual Skills: How to Listen to a Podcast 37 minutes, 58 seconds in duration. Your host: David Schmitt, Ph.D. I want to help you become better informed, active and safe post-COVID. I am trying to improve my podcasting. Here are some tips on getting more from podcasts. Chronological Notes & Amplifications 0:55 Talk radio to pod…

1
Episode 17: The Empty Bookcase Beginning for Building a Library and for Rebuilding a Civilization 18:59

4y ago18:59

18:59

In this 'Adventures in Civic Renewal Series', your host, David Schmitt, discusses a psychological device for initiating your grand project for building a home or office library. This is especially beneficial for families with children to educate, but it is important for individuals as well. Supporting, or beginning anew, your habit of reading is a …

1
Episode 16: A Deadly & Evolutionarily-Maladaptive Vexine: A Dirty Die---A Schmitt & Atwill Review of the Weinstein, Malone & Kirsch DARKHORSE Interview 1:03:34

4y ago1:03:34

1:03:34

Dave Schmitt, Ph.D., a neurobiologist, and Mr. Joe Atwill, a software entrepreneur, discuss the accumulation of empirical evidence that is amassing and vindicating the conclusions that have been presented here, since December 2020, on The Second Society Podcast and arrived at using the 'a priori' rationalist reasoning available to us at the time. D…

1
The evolution of the asset-centric approach in biotech venture capital 47:29

4y ago47:29

47:29

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture cap…

1
Episode 15: Oppressed Student Group Organizes for Action 1:20:50

4y ago1:20:50

1:20:50

Conservative, traditionalist, Right-leaning, Christian, nationalist, Identitarian, European-rights and Republican students as well as groups are being targeted, harassed, vilified, oppressed and even criminally harassed on campuses across America. These courageous and energized young people are learning the language and strategies of resistance and…

1
Episode 14: Patrick Wood and Dave Schmitt Discuss Magnets, Vaccines and Technocracy 53:55

4y ago53:55

53:55

Patrick Wood is the author of 'Technocracy: The Hard Road to World Order' (2018), 'Globalization and the Crucible of Global Banking' (2018), 'Trilaterals Over Washington, Volumes I & II' (1979, 2017) and 'Technocracy Rising: The Trojan Horse of Global Transformation' (2014). Mr. Wood is also the Editor-in-Chief of an extremely useful website, 'Tech…

1
Episode 13: Ordered Myoglobin in Muscles With Many Type I Fibers May Account for Attraction of Magnets Unrelated to Vaccination 19:09

4y ago19:09

19:09

Many online videos have been made purportedly demonstrating the attraction of magnets to COVID-vaccine injection sites in the deltoid muscles. Dr. Schmitt reports the results of experimentation with a 18 mm in diameter by 2 mm neodynium magnets places at various locations of the body. Over the antigravity, postural muscles, attraction of the magnet…

1
Drugs to Watch 2021 23:50

4y ago23:50

23:50

Clarivate market experts break down the opportunities and potential threats for 2021’s Drugs to Watch – the key drugs expected to be blockbusters by 2026. Hosted on Acast. See acast.com/privacy for more information.

1
Episode 12: Viral Spike Protein Alone--Apart from Infection with Viral Nucleic Acid--Damages Cells Lining Blood Vessels 35:24

4y ago35:24

35:24

Joe Atwill and Dave Schmitt have a conversation regarding a recent report that the SARS-CoV-2 Spike Protein is, by itself, detrimental to the functioning of cells lining the blood vessels. See, Lei et al., Circ. Res., here: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318902 In good faith, and based on very legitimate concerns, some oppos…

1
Episode 11: A Colossal Government Syringe to Subdue the Colossal European Male 1:06:51

4y ago1:06:51

1:06:51

Joe Atwill joins Dave Schmitt to continue the urgent conversation regarding the Fascistic oppression of Americans and White Europeans worldwide. Over the last several days in the United States, we have seen the tyrannical placing of Right-leaning commentator, Nick Fuentes, on a no-fly list to prevent him from speaking in Florida at a conference dev…

1
Episode 10: Timothy Kelly & Dave Schmitt: A COVID World Without Catholicism 1:51:16

4y ago1:51:16

1:51:16

Tim Kelly is the host of a profoundly popular and worthwhile podcast suite: "Our Interesting Times " and "Powers and Principalities." Several hundred podcasts available. This will get you started: https://www.podomatic.com/podcasts/tkelly6785757 Here, Tim and I discuss the woeful state of the world in which we find ourselves amidst this manufacture…

1
Episode 9: Professor McCall & Dr. Schmitt - The Added Dilemma of Self-mutilation and the mRNA Pseudo-vaccines 1:05:35

4y ago1:05:35

1:05:35

This is a recording of an interview between Professor Brian McCall of Catholic Family News and Dr. David Schmitt on December 30, 2020. At the time of the recording, the Moderna- and Pfizer-brand "vaccines," such as they are called, were newly available. Some Catholic bishops warned their flocks not to take these injections because of their being "t…

1
Episode 8: Mass Arrests, The PCR Scam, COVID Bribery, Foreknowledge Concerning the COVID Shutdown and Malignant Obedience 58:11

4y ago58:11

58:11

In this episode, David Schmitt discusses with his guest in conversation matters that should be critical for all of the listeners. There was a detaining and threatened arrest during a Mass at Holy Trinity Catholic Church in Dallas, Texas. See: Pregnant Mother Threatened to be Arrested during Mass: interview with Dr. Taylor Marshall, March 27, 2021, …

1
Episode 7: Our Tools Against the War On Our Common Immunity, Citizenship and Personhood 51:17

4+ y ago51:17

51:17

In this podcast Joe Atwill and Dave Schmitt discuss: (1) Dr. Geert Vanden Bossche's concerns regarding 'viral escape' and and what he identifies as the mistaken policy of mass vaccination with the prophylactic vaccines that are currently available. Joe and Dave discuss what must be considered as our ecological immune system and the importance of a …

1
Episode 6: Dubious Claims Regarding the Johnson & Johnson Pseudovaccine 45:40

4+ y ago45:40

45:40

Joe Atwill and David Schmitt Review the Memorandum for an Emergency Use Authorization (EUA) for an UNAPPROVED [emphasis ours] Product Review Submitted by Janssen Biotech, Inc.(a J&J subsidiary), Application No. 27205. This application for an EUA is for the Janssen COVID-19 "vaccine" [such as it is called by its proponents] (Ad26.COV2.s). Many impor…

1
Episode 5: Catholic Activism Against the COVID Tyranny 46:13

4+ y ago46:13

46:13

The people of the world are facing a crisis of exaggerated, utterly-disproportionate and inappropriate response to a dubious or presumed novel virus. Joe Atwill and Dave Schmitt discuss a unique opportunity that Catholics have for petitioning divine (and, of course, therefore miraculous) and naturally understandable intervention by peacefully raisi…

1
People, Cells and Human Lattices: A RESET of Our Own 1:05:34

4+ y ago1:05:34

1:05:34

Powerful forces are aligning against the righteous ordering of nations, societies and Civilization. That set of forces will be referred to here as "The Medium," or simply the "Medium." which is the collection of governments, corporations, banks, academia, journalism, the arts and industries---all increasingly empowered by a consolidation of control…

1
Episode 3: Ascending from Washington - A New Nation 12:01

4+ y ago12:01

12:01

This is a short encouragement for those assembling in Washington, D.C., January 5-6, 2021 to urge the government of the United States to recognize the fraudulent nature of Senator Joe Biden's claim to the Presidency and to respond and, in turn to certify the landslide, true election of President Trump as President. We will, henceforth control the n…

1
Episode 2: The Coronavirus and the 'Vigilant Bird' Concept 1:24:36

4+ y ago1:24:36

1:24:36

Dave Schmitt and Joe Atwill leapfrog from the manipulated events of 2020, the so-called COVID crisis, the riots the Stolen Election of 2020 in the U.S., and utilize biological and historical common sense to encourage the public to regain a healthy awareness of the larger threat. Vigilance is a natural feature of intelligent beings. Rational examina…

1
Episode 1: Schmitt & Atwill: Hard Problems-Real Choices - Episode 1: Concerns About mRNA Vaccines 47:40

4+ y ago47:40

47:40

Episode 1. December 9, 2020. Joe Atwill and David Schmitt discuss possible, serious problems with the mRNA vaccines that are being rushed into forced, universal administration. Allergic reactions, autoimmune & neurological disease, infections and cancer are some of the imaginable down-the-road hazards. The hosts introduce novel topics forming a big…

1
Utilizing pluripotent stem cells in cell therapy 25:55

4+ y ago25:55

25:55

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Brian Culley, CEO of Lineage Cell Therapeutics. Brian and Mike discuss the company’s cell therapy program, utilizing pluripotent stem cells, initially targeting dry age-related macular degeneration, acute spinal cord i…

1
The past, present and future of next generation sequencing 30:07

4+ y ago30:07

30:07

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Nick McCooke, CEO of Longas Technologies. Having been at the forefront of developing next generation sequencing, Nick talks to Mike about his past work, current projects and future predictions for this key technology in …

1
COVID-19, multi-stem clinical trials and a new way of fundraising 50:05

4+ y ago50:05

50:05

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Gil Van Bokkelen, founder, chairman and CEO of Athersys Inc. They discuss the company’s clinical program that is focusing on a special class of stem cells which display very unique properties and have been obtained from healthy young consenting don…

1
Early planning key to successful access and product launch 29:35

4+ y ago29:35

29:35

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Alison Kneen, Senior Vice President, Global Market Access and Head of the Centre of Innovation and Regulatory Science (CIRS) and DRG Abacus. Learn why early and thorough planning is so important for a successful product launch, and how A…

1
Transforming the treatment of cancer with oncolytic viruses 33:06

4+ y ago33:06

33:06

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals. Stephen shares his journey from academia at the Mayo Clinic to founding Vyriad, and eventually…

1
Possible treatment for COVID-19 related respiratory failure 21:37

4+ y ago21:37

21:37

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Jonathan Javitt, CEO of NeuroRx. Dr Javitt discusses how NeuroRx is working in collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COV…

1
Pivoting a product launch during the pandemic 35:23

4+ y ago35:23

35:23

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Bryan Witherbee, President & CEO of Adarza BioSystems. Earlier this year, Adarza raised 25 million dollars to support the full commercialization of Ziva, an automated biological platform which delivers comprehensive, h…

1
How Glympse Bio oversubscribed their Series B funding amidst the pandemic 44:12

4+ y ago44:12

44:12

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Caroline Loew, President and CEO from Glympse Bio. They discuss the biotech’s focus on both disease detection and response to treatment using bioengineered sensors, starting with NASH. Dr. Loew also shares career a…

1
A novel approach to treating neurodegenerative disease 26:19

4+ y ago26:19

26:19

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration…

1
An update from biopharma’s hotspot 27:26

4+ y ago27:26

27:26

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, Part of Clarivate talks to Bob Coughlin, president and CEO of the Massachusetts Biotechnology Council. Bob provides insights from what is unarguably the world’s number one biopharma hotspot. Bob and Mike discuss how the industry…

1
Addressing strategic challenges for biotech companies 30:55

4+ y ago30:55

30:55

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Dr Srikanth Rajagopal (or Doc, as he is fondly referred to). Doc, a partner at DRG Consulting, whose areas of expertise include product and portfolio strategy to name a few, chatted to us about common strategic challenges biotechnology comp…

1
Collaborating with officials to continue developments 39:08

4+ y ago39:08

39:08

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Joe Panetta, President and CEO of BIOCOM. Joe talks around how BIOCOM has worked closely with government officials to ensure the life science community can continue to function throughout the COVID-19 pandemic, and how t…

1
How including patients can help with the fight against Parkinson’s Disease 21:27

4+ y ago21:27

21:27

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Charlotte Allen and Russ Bradford from Parkinson’s Concierge. Russ and Charlotte offer a unique insight into how being a patient centric organisation enables them to help the Parkinson’s Disease community improve their q…

1
Maximising R+D efforts through better epidemiology understanding 23:13

4+ y ago23:13

23:13

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Mike Hughes, Senior Director of Epidemiology at DRG. With epidemiology entering our daily vernacular, thanks to the Covid-19 pandemic, Mike gives a definition of what it is, the approaches used to model epidemiology ass…

1
Bringing together minds to combat COVID-19 27:01

4+ y ago27:01

27:01

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Sir Mene Pangalos, Executive Vice President at AstraZeneca. Sir Mene talks to Mike about AstraZeneca's learnings from helping Chinese colleagues combat Coronavirus at the end of 2019, and then expanding input as it becam…